Gabriel Levin, Clinical Fellow at McGill University Health Centre and Director of Oncology at CureLab Oncology, shared a post on LinkedIn:
“I love this new paper of us.
This project looked at something I find fascinating in oncology: what actually happens after a positive randomized trial is published. Do new treatments truly make their way into real-world practice? How fast? And for whom?
I feel lucky to work with people I deeply respect. Thank you to Lucy Gilbert for constant mentorship and belief in asking ambitious questions, to Reitan Ribeiro for being an incredible collaborator and friend, and to Pedro Ramirez for all his efforts and time invested in me.
I thank all co-authors for the opportunity to learn from leaders who continue to shape gynecologic oncology worldwide.”
Title: From Evidence to Practice: National Patterns of HIPEC Use and Survival in Advanced Ovarian Cancer
Authors: Gabriel Levin, Lucy Gilbert, Reitan Ribeiro, Rene Pareja, Raanan Meyer, Pedro T. Ramirez
Read the Full Article.
Other articles featuring Gabriel Levin on OncoDaily.